Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES USA: Oligonucleotide & Peptide Therapeutics
April 26-29, 2027
Hynes Convention CenterBoston, MA
Menu

Kurt Vagle
Senior Director - Chemical Development RNAi CMC at Novo Nordisk
Speaker

Profile

Senior Director at Novo Nordisk, leads chemical development for oligonucleotide therapeutics, specializing in oligonucleotide manufacturing, phosphoramidite scale‑up, and sustainable oligonucleotide synthesis strategies. Kurt has spent his 30-year career in the field of modified nucleoside and oligonucleotide chemistry.

Agenda Sessions

  • New SPOS Support to Drive Next Generation Manufacturing

    , 2:30pm
    View Session

At this event

Prev
Next
Adam Oxley, PhD
Deputy Vice President of Membranes and Purification
Exactmer

See Kurt at TIDES USA: Oligonucleotide & Peptide Therapeutics